Ferenci, P.; Asselah, T.; Foster, G. R. et al.
FALDAPREVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONIC HCV GENOTYPE-1 TREATMENT-NAIVE PATIENTS: FINAL RESULTS FROM STARTVERSO1, A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIALJOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S569-S570
Ferenci, P.; Asselah, T.; Foster, G. R. et al.
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trialJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. Bd. 28. 2013 S. 157-158
Moreno, Christophe; Ferenci, Peter; Asselah, Tarik et al.
Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 TrialAMERICAN JOURNAL OF GASTROENTEROLOGY. Bd. 108. 2013 S. S145-S145
Lieb, K; Heßlinger, B; Jacob, G
Fallgeschichten Psychiatrie und Psychotherapie4. Aufl. München: Urban & Fischer 2013 1 S.
Barreiros, Ana Paula; Galle, Peter R.; Otto, Gerd
Familial Amyloid PolyneuropathyDIGESTIVE DISEASES. Bd. 31. H. 1. 2013 S. 170-174
Bruttger, J.; Woertge, S.; Yona, S. et al.
FAST REPOPULATION OF MICROGLIA AFTER ABLATIONGLIA. Bd. 61. 2013 S. S51-S52
Wilden, S.; Rudolph, B.; Stanger, C. et al.
Fatal Leukopenia Under Treatment with VemurafenibJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 11. 2013 S. 86-86
Hinz, Andreas; Finck Barboza, Carolyn; Barradas, Susana et al.
Fatigue in the General Population of Colombia - Normative Values for the Multidimensional Fatigue Inventory MFI-20ONKOLOGIE. Bd. 36. H. 7-8. 2013 S. 403-407
Menke, J.; Gortner, J.; Schermuly, I. et al.
Fatigue Symptoms in SLE - pathophysiological Significance of NR2-Auto-Ab.INTERNIST. Bd. 54. 2013 S. 51-52
Menke, J.; Schermuly, I.; Schwarting, A.
Fatigue-Symptoms in SLE - pathophysiological Significance of NR2-Auto-AkZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 72. 2013 S. 142-142